HUMAN IMMUNODEFICIENCY VIRUS (HIV)
Clinical trials for HUMAN IMMUNODEFICIENCY VIRUS (HIV) explained in plain language.
Never miss a new study
Get alerted when new HUMAN IMMUNODEFICIENCY VIRUS (HIV) trials appear
Sign up with your email to follow new studies for HUMAN IMMUNODEFICIENCY VIRUS (HIV), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New HIV vaccine candidate moves to human safety testing
⭐️ VACCINE ⭐️ CompletedThis study tested an experimental HIV vaccine in 65 healthy, HIV-negative adults to find the safest and most effective dose of an immune-boosting ingredient (adjuvant). Participants received three shots over two months and were monitored for side effects and immune responses for …
Matched conditions: HUMAN IMMUNODEFICIENCY VIRUS (HIV)
Phase: PHASE1 • Sponsor: U.S. Army Medical Research and Development Command • Aim: ⭐️ VACCINE ⭐️
Last updated May 12, 2026 13:41 UTC
-
Vitamin D3 shows promise for HIV immune support
Disease control CompletedThis study looked at whether taking vitamin D3 for 3 months can lower inflammation and boost immune cells in people with HIV who are already on antiretroviral therapy. Twenty adults with early-stage HIV took vitamin D3 supplements. Researchers measured changes in inflammation mar…
Matched conditions: HUMAN IMMUNODEFICIENCY VIRUS (HIV)
Phase: NA • Sponsor: Universitas Sebelas Maret • Aim: Disease control
Last updated May 17, 2026 03:15 UTC
-
Rural oklahoma program aims to stop HIV spread
Prevention CompletedThis study tested a program to help young men in rural Oklahoma get tested for HIV and syphilis, use condoms, and take PrEP (a daily pill that prevents HIV). The program was designed for American Indian men and men who have sex with men. The goal was to see if the program was eas…
Matched conditions: HUMAN IMMUNODEFICIENCY VIRUS (HIV)
Phase: NA • Sponsor: Northern Arizona University • Aim: Prevention
Last updated May 15, 2026 11:56 UTC